Portolan Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-108,632
| Closed | -$2.82M | – | 124 |
|
|
2023
Q2 | $2.82M | Sell |
108,632
-106,443
| -49% | -$2.77M | 0.25% | 94 |
|
|
2023
Q1 | $6.18M | Buy |
215,075
+7,175
| +3% | +$206K | 0.59% | 60 |
|
|
2022
Q4 | $6.15M | Sell |
207,900
-26,703
| -11% | -$790K | 0.61% | 59 |
|
|
2022
Q3 | $5.58M | Sell |
234,603
-1,369
| -0.6% | -$32.6K | 0.59% | 61 |
|
|
2022
Q2 | $5.27M | Buy |
+235,972
| New | +$5.27M | 0.53% | 67 |
|
|
2021
Q3 | – | Sell |
-50,177
| Closed | -$2.17M | – | 135 |
|
|
2021
Q2 | $2.17M | Buy |
+50,177
| New | +$2.17M | 0.16% | 110 |
|
|
2020
Q4 | – | Sell |
-7,708
| Closed | -$273K | – | 167 |
|
|
2020
Q3 | $273K | Sell |
7,708
-2,106
| -21% | -$74.6K | 0.03% | 139 |
|
|
2020
Q2 | $370K | Sell |
9,814
-1,218
| -11% | -$45.9K | 0.04% | 127 |
|
|
2020
Q1 | $319K | Sell |
11,032
-3,429
| -24% | -$99.2K | 0.05% | 112 |
|
|
2019
Q4 | $750K | Hold |
14,461
| – | – | 0.08% | 94 |
|
|
2019
Q3 | $794K | Sell |
14,461
-967
| -6% | -$53.1K | 0.09% | 83 |
|
|
2019
Q2 | $627K | Buy |
15,428
+772
| +5% | +$31.4K | 0.07% | 86 |
|
|
2019
Q1 | $443K | Sell |
14,656
-103,853
| -88% | -$3.14M | 0.05% | 85 |
|
|
2018
Q4 | $3.98M | Sell |
118,509
-12,873
| -10% | -$433K | 0.49% | 57 |
|
|
2018
Q3 | $5.54M | Sell |
131,382
-30,698
| -19% | -$1.29M | 0.55% | 58 |
|
|
2018
Q2 | $5.19M | Buy |
162,080
+104,148
| +180% | +$3.33M | 0.53% | 62 |
|
|
2018
Q1 | $2.88M | Buy |
57,932
+43,376
| +298% | +$2.16M | 0.32% | 80 |
|
|
2017
Q4 | $785K | Sell |
14,556
-10
| -0.1% | -$539 | 0.09% | 113 |
|
|
2017
Q3 | $845K | Hold |
14,566
| – | – | 0.1% | 107 |
|
|
2017
Q2 | $719K | Sell |
14,566
-241
| -2% | -$11.9K | 0.09% | 112 |
|
|
2017
Q1 | $643K | Sell |
14,807
-53,085
| -78% | -$2.31M | 0.08% | 119 |
|
|
2016
Q4 | $3.32M | Buy |
67,892
+2,617
| +4% | +$128K | 0.45% | 85 |
|
|
2016
Q3 | $3.12M | Buy |
65,275
+13,735
| +27% | +$657K | 0.43% | 72 |
|
|
2016
Q2 | $2.77M | Sell |
51,540
-79,399
| -61% | -$4.26M | 0.4% | 88 |
|
|
2016
Q1 | $5.86M | Sell |
130,939
-357,656
| -73% | -$16M | 0.78% | 46 |
|
|
2015
Q4 | $18.6M | Sell |
488,595
-150,254
| -24% | -$5.73M | 2.36% | 6 |
|
|
2015
Q3 | $20.3M | Buy |
638,849
+144,436
| +29% | +$4.6M | 2.69% | 4 |
|
|
2015
Q2 | $16.3M | Buy |
494,413
+129,950
| +36% | +$4.29M | 2.28% | 7 |
|
|
2015
Q1 | $15M | Buy |
364,463
+56,332
| +18% | +$2.32M | 2.75% | 3 |
|
|
2014
Q4 | $12.6M | Buy |
308,131
+55,298
| +22% | +$2.25M | 2.51% | 3 |
|
|
2014
Q3 | $9.27M | Buy |
252,833
+35,728
| +16% | +$1.31M | 2.11% | 5 |
|
|
2014
Q2 | $10.1M | Buy |
217,105
+41,141
| +23% | +$1.91M | 2.2% | 5 |
|
|
2014
Q1 | $7.23M | Buy |
175,964
+43,132
| +32% | +$1.77M | 1.67% | 12 |
|
|
2013
Q4 | $5.07M | Sell |
132,832
-11,126
| -8% | -$425K | 1.12% | 31 |
|
|
2013
Q3 | $3.44M | Sell |
143,958
-40,473
| -22% | -$967K | 0.9% | 43 |
|
|
2013
Q2 | $3.14M | Buy |
+184,431
| New | +$3.14M | 0.89% | 44 |
|